A newly discovered 32-amino-acid peptide from tree frog skin — the first cathelicidin ever found in tree frogs — kills bacteria by punching holes in their membranes and also reduces inflammation by blocking key immune signaling pathways.
First tree frog cathelicidinOut of 7,639 known amphibian species, only 10 had yielded cathelicidins before this study — and none were tree frogs until cathelicidin-PP was discovered.
What the researchers found
Cathelicidin-PP is a 32-residue peptide (ASENGKCNLLCLVKKKLRAVGNVIKTVVGKIA) that adopts a β-sheet structure in membrane-mimetic environments. It demonstrated potent antimicrobial activity against bacteria and fungi, with particular effectiveness against Gram-negative bacteria. Scanning electron microscopy confirmed it kills bacteria by disrupting membrane integrity.
Beyond direct antimicrobial action, cathelicidin-PP significantly inhibited LPS-stimulated production of nitric oxide, TNF-α, IL-1β, and IL-6 in macrophages. This anti-inflammatory effect involved both MAPK (ERK, JNK, and p38) and NF-κB signaling pathways. The peptide also partially neutralized LPS in a dose-dependent manner. In live tree frogs, bacterial infection caused increased cathelicidin-PP expression in immune-related tissues, confirming its role in natural host defense.
Why it matters
With antibiotic resistance rising globally, finding new antimicrobial compounds is urgent. Cathelicidins are especially interesting because they combine direct germ-killing with immune regulation — they fight infection on two fronts simultaneously. This discovery expands the known diversity of cathelicidins into tree frogs, a massive and largely untapped reservoir of potential drug leads. The fact that cathelicidin-PP has low toxicity to mammalian cells while retaining both antimicrobial and anti-inflammatory activity makes it a promising template for new drug development.
The numbers in context
32 amino acids; β-sheet structure; inhibits TNF-α, IL-1β, IL-6, NO; MAPK (ERK, JNK, p38) and NF-κB pathways; dose-dependent LPS neutralization; low cytotoxicity
How the study worked
Researchers purified cathelicidin-PP from Polypedates puerensis tree frog skin and determined its amino acid sequence. They used circular dichroism spectroscopy to analyze its structure, antimicrobial assays to test its germ-killing ability, and scanning electron microscopy to visualize how it destroys bacterial membranes. Anti-inflammatory properties were tested in LPS-stimulated mouse peritoneal macrophages by measuring cytokines and nitric oxide. LPS neutralization was assessed in dose-response assays. Finally, qPCR was used to measure cathelicidin-PP expression in frog tissues after bacterial infection.
Who was studied
Polypedates puerensis tree frog skin peptide; tested on bacteria, fungi, and mouse macrophages
What this study cannot tell us
All experiments were conducted in vitro or ex vivo — there were no animal infection models testing whether cathelicidin-PP protects against disease in a living organism. The peptide was tested against a limited panel of microorganisms. No pharmacokinetic data (how long it lasts in the body) or toxicity studies in whole animals were performed. The clinical translatability of a frog-derived peptide to human medicine is unknown.
How to read the evidence
Rated preliminary: thorough in vitro characterization of a novel peptide with multiple complementary assays, but no in vivo efficacy data. The study is primarily a discovery and characterization report, not a therapeutic validation.
When this study was published
Published in 2017 in Amino Acids. The findings are relevant to ongoing efforts to discover new antimicrobial peptides from natural sources, especially as antibiotic resistance continues to worsen.
The bigger picture
Amphibian skin is one of nature's richest sources of antimicrobial peptides, with over 7,600 frog species representing a vast library of potential drug candidates. Yet cathelicidins — one of the most important antimicrobial peptide families in mammals (including the human LL-37) — have been barely explored in amphibians, with only 20 identified from 10 species at the time of this study. Finding the first tree frog cathelicidin with dual antimicrobial and immunomodulatory properties extends our understanding of how this ancient peptide family has evolved across vertebrate lineages.
Questions still open
- Could cathelicidin-PP or derivatives be developed into a therapeutic antimicrobial for drug-resistant infections?
- How does cathelicidin-PP compare in potency and safety to human cathelicidin LL-37 and other amphibian antimicrobial peptides?
- Are there other undiscovered cathelicidins in the thousands of frog species yet to be screened?
Common questions
What is a cathelicidin and why is finding one in a tree frog important?
Could a frog skin peptide really become a medicine for humans?
Read the original research
The first identified cathelicidin from tree frogs possesses anti-inflammatory and partial LPS neutralization activities.
Amino acids, 49(9), 1571-1585
Citation
Mu, Lixian; Zhou, Lei; Yang, Juanjuan; Zhuang, Li; Tang, Jing; Liu, Tong; Wu, Jing; Yang, Hailong. (2017). The first identified cathelicidin from tree frogs possesses anti-inflammatory and partial LPS neutralization activities.. Amino acids, 49(9), 1571-1585. https://doi.org/10.1007/s00726-017-2449-7